Urine and vaginal-fluid test could reduce invasive womb-cancer checks

Doctors have developed a test that could help rule out womb cancer in women who experience bleeding after menopause, according to the supplied report. The approach uses samples of urine and vaginal fluid rather than relying only on invasive examinations. It raises the possibility that women assessed as being at lower risk could avoid some internal tests.

The report says the test could spare thousands of women each year from internal ultrasounds and hysteroscopies. Those procedures can be uncomfortable and costly for healthcare systems, although the supplied material does not provide figures for the number of women involved or the cost of current testing. Post-menopausal bleeding can lead to further investigation for womb cancer.

The proposed test is described as a way of helping doctors rule out the disease, rather than as a confirmed replacement for every existing examination. Doctors involved in the development believe the approach could transform care for thousands of women each year. The supplied account does not identify the researchers, provide results from a study, or state the test’s accuracy.

It also gives no details about when the test might become available, whether it has undergone regulatory assessment, or how clinicians would use it alongside ultrasound and hysteroscopy. Further information about those issues is not included in the source material.